[Pharmacological correction of the cytogenetic effects of cisplatin].
O L Voronova, O V Neupokoeva, E P Fedorova, A E Prosenko, A A Churin
Index: Eksp. Klin. Farmakol. 73(10) , 37-9, (2010)
Full Text: HTML
Abstract
Beginning with the first hours of experiments, cisplatin evoked an increase of chromosomal aberrations in CBA/CaLac bone marrow cells. Significant increase of structural infringements of chromosomes due to chromatid breaks was revealed in metaphase plates of murine bone marrow preparations through 24 h after cisplatin intraperitoneal introduction. In late terms of research (90th day), the high level of aberrations of chromosomes was retained. The most pronounced correction of cisplatin mutagenicity was achieved using a preliminary course of thiophan introduction.
Related Compounds
Related Articles:
2014-10-13
[Biomacromolecules 15(10) , 3802-10, (2014)]
2005-05-05
[J. Med. Chem. 48 , 3269-79, (2005)]
2015-01-01
[J. Chromatogr. A. 1421 , 154-61, (2015)]
2011-01-01
[Chem. Biol. 18(12) , 1631-9, (2011)]
2011-01-01
[Eksp. Klin. Farmakol. 74(8) , 37-40, (2011)]